The interaction of genetic and environmental factors in the etiology of hypertension

Physiological Research

Volumn 58, Issue SUPPL.2, 2009, Pages 33-42

  Kunes J ^a,b   Zicha, J ^a,b  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Environment; Epigenetics; Genes; Hypertension; Metabolic syndrome

Indexed keywords

AGE; BLOOD PRESSURE; ENVIRONMENT; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; REVIEW; RISK FACTOR;

AGE FACTORS; BLOOD PRESSURE; ENVIRONMENT; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; PEDIGREE; PHENOTYPE; RISK FACTORS;

EID: 77949535945     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (46)

1. BARKER DJP, OSMOND C, GOLDING J, KUH D, WADSWORTH MEJ: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298: 564-567, 1989.
2. BOTSTEIN D, RICH N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33: 228-237, 2003.
3. BURDGE GC, HANSON MA, SLATER-JEFFERIES JL, LILLYCROP KA: Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr 97: 1036-1046, 2007
4. CICILA GT: Strategy for uncovering complex determinants of hypertension using animal models. Curr Hypertens Rep 2: 1-10, 2000.
5. DE BOO HA, HARDING JE: The developmental origins of adult disease (Barker) hypothesis. Aust N Z J Obstet Gynaecol 46: 4-14, 2006.
6. DORIS P: Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 39: 323-331, 2002.
7. EATON SB: Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 84: 739-749, 1988.
8. EATON SB, EATON SB: An evolutionary perspective on human physical activity: implications for healts. Comp Biochem Physiol A 136: 153-159, 2003.
9. EGGER G, LIANG G, APARICIO A, JONES PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463, 2004.
10. ERIKSSON JG, FORSÓN TJ, KAJANTIE E, OSMOND C, BARKER DJP: Childhood growth and hypertension in later life. Hypertension 49: 1414-1421, 2007.
11. FALKNER B, HULMAN S, KUSHNER H: Effect of birth weight on blood pressure and body size in early adolescence. Hypertension 43: 203-207, 2004.
12. GIBSON G: Epistasis and pleiotropy as natural properties of transcriptional regulation. Theor Popul Biol 49: 58-89, 1996.
13. GLAZIER AM, NADEU JH, AITMAN TJ: Finding genes that underlie complex traits. Sciences 298: 2345-2349, 2002.
14. GREENLAND S, ROTHMAN KJ: Concepts of interaction. In: Modern Epidemiology ROTHMAN KJ, GREENLAND S. (eds), Lippincott-Raven, Philadelphia, PA, 1998, pp 329-342.
15. HAMET P, PAUSOVA Z, DUMAS P, SUN YL, TREMBLAY J, PRAVENEC M, KUNES J, KRENOVA D, KREN V: Newborn and adult recombinant inbred strains: a tool to search for genetic determinants of target organ damage in hypertension. Kidney Int 53: 1488-1492, 1998.
16. HUXLEY RR, SHIEL AW, LAW CM: The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systemic review of the literature. J Hypertens 18: 815-831, 2000.
17. IYER SN, LU D, KATOVICH MJ, RAIZADA MK: Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci U S A 93: 9960-9965, 1996.
18. JACOB JH: Physiological genetics: aplication to hypertension research. Clin Exp Pharmacol Physiol 26: 530-535, 1999.
19. JAENISCH R, BIRD A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33: 245-254, 2003.
20. JIMENEZ-SANCHEZ G, CHILDS B, VALLE D: Human disease genes. Nature 409: 853-835, 2001.
21. KADLECOVÁ M, DOBEŠOVÁ Z, ZICHA J, KUNEŠ J: Abnormal Igf2 gene in Prague hereditary hypertriglyceridemic rats: its relation to blood pressure and plasma lipids. Mol Cell Biochem 314: 37-43, 2008.
22. KATOVICH MJ, GELBAND CH, REAVES P, WANG HW, RAIZADA MK: Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR. Am J Physiol 277: H1260-H1264, 1999.
23. KEREM B, ROMMENS JM, BUCHANAN JA, MARKIEWICZ D, COX TK, CHAKRAVARTI A, BUCHWALD M, TSUI LC: Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080, 1989.
24. KUNEŠ J, ZICHA J: Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci 111: 295-305, 2006.
25. MARTENS JR, REAVES PY, LU D, KATOVICH MJ, BERECEK KH, BISHOP SP, RAIZADA MK, GELBAND CH: Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc Natl Acad Sci U S A 95: 2664-2669, 1998.
26. MORGAN HD, SUTHERLAND HG, MARTIN DI, WHITELAW E: Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23: 314-318, 1999.
27. MYERS J, PRAKASH M, FROELICHER V, DO D, PARTINGTON S, ATWOOD JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801, 2002.
28. NAFEE TM, FARRELL WE, CARROLL WD, FRYER AA, ISMAIL KMK: Epigenetic control of fetal gene expression. BJOG 115: 158-168, 2008.
29. PELTONEN L, MCKUSICK VA: Dissecting human disease in the postgenomic era. Science 291: 1224-1229, 2001.
30. PICKERING GW: The nature of essential hypertension. Lancet ii: 1027-1028, 1959.
31. PLATT R: Heredity in hypertension. Q J Med 16: 111-133, 1947.
32. RAPP JP: A paradigm for identification of primary genetic causes of hypertension in rats. Hypertension 5: I198-I203, 1983.
33. RAPP JP: Genetic analysis of inherited hypertension in the rat. Physiol Rev 8: 135-172, 2000.
34. REIK W, DEAN W, WALTER J: Epigenetic reprogramming in mammalian development. Science 293: 1089-1093, 2001.
35. RIORDAN JR, ROMMENS JM, KEREM B, ALON N, ROZMAHEL R, GRZELCZAK Z, ZIELENSKI J, LOK S, PLAVSIC N, CHOU JL: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
36. ROYER-POKORA B, KUNKEL LM, MONACO AP, GOFF SC, NEWBURGER PE, BAEHNER RL, COLE FS, CURNUTTE JT, ORKIN SH: Cloning the gene for an inherited human disorder - chronic granulomatous disease-on the basis of its chromosomal location. Nature 322: 32-38, 1986.
37. SAVITSKY K, BAR-SHIRA A, GILAD S, ROTMAN G, ZIV Y, VANAGAITE L, TAGLE DA, SMITH S, UZIEL T, SFEZ S, ASHKENAZI M, PECKER I, FRYDMAN M, HARNIK R, PATANJALI SR, SIMMONS A, CLINES GA, SARTIEL A, GATTI RA, CHESSA L, SANAL O, LAVIN MF, JASPERS NG, TAYLOR AM, ARLETT CF, MIKI T, WEISSMAN SM, LOVETT M, COLLINS FS, SHILOH Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
38. SURANI MA: Reprogramming of genome function through epigenetic inheritance. Nature 414: 122-128, 2001.
39. SVENSON KL, BOGUE MA, PETERS LL: Identifying new mouse models of cardiovascular disease: a review of highthroughput screens of mutagenized and inbred strains. J Appl Physiol 94: 1650-1659, 2003.
40. TIMBERLAKE DS, O'CONNOR DT, PARMER RJ: Molecular genetics of essential hypertension: recent results and emerging strategies. Curr Opin Nephrol Hypertens 10: 71-79, 2001.
41. VEERASINGHAM SJ, SELLERS KW, RAIZADA MK: Functional genomics as an emerging strategy for the investigation of centralmechanisms in experimental hypertension. Prog Biophys Mol Biol 84: 107-123, 2004.
42. WATERLAND RA, JIRTLE RL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23: 5293-5300, 2003.
43. WATERLAND RA, JIRTLE RL: Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63-68, 2004.
44. WOLFF GL, KODELL RL, MOORE SR, COONEY CA: Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12: 949-957, 1998.
45. ZANDI-NEJAD K, LUYCKX VA, BRENNER BM: Adult hypertensuion and kidney disease. The role of fetal programming. Hypertension 47: 502-508, 2006.
46. ZICHA J, KUNEŠ J: Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 79: 1227-1282, 1999.